Ameritas Advisory Services’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Ameritas Advisory Services's NVS Position: Q1 2026 in Review
Ameritas Advisory Services reduced its Novartis (NVS) stake by 51% in Q1 2026, selling an estimated $381K and leaving 2,391 shares worth $365K. The position accounts for 0.01% of the portfolio, ranked #689.
Ameritas Advisory Services first reported a position in NVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.28M in Q3 2023. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Ameritas Advisory Services held 2,391 shares of Novartis worth $365K as of Q1 2026.
- Ameritas Advisory Services sold 2,484 Novartis shares in Q1 2026, an estimated $381K.
- Novartis made up 0.01% of Ameritas Advisory Services's portfolio in Q1 2026, its #689 holding.
- Ameritas Advisory Services first reported a position in Novartis in Q4 2021 and has held it in 18 quarters since.
- Ameritas Advisory Services's Novartis position peaked at $1.28M in Q3 2023.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Ameritas Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.